Literature DB >> 3341450

Immunocytochemical distribution of a breast carcinoma associated glycoprotein identified by monoclonal antibodies.

R Mesa-Tejada1, R B Palakodety, J A Leon, A O Khatcherian, C J Greaton.   

Abstract

A glycoprotein, BCA-225 (Mr 225,000-250,000), has been identified in cells and spent medium of clone 11 T47D breast carcinoma cells by three murine monoclonal antibodies, CU18, CU26, and CU46. The antigen was localized in paraffin sections of 167/178 (94%) Bouin's-fixed human breast carcinoma tissues and few other carcinomas (1/8 lung [squamous], 4/4 uterine cervix) in an intracellular pattern, whereas an apical or glycocalyx distribution was seen in several normal tissues, benign lesions, and malignant tumors. Although the immunocytochemical staining patterns observed with these antibodies have many similarities to those described with other previously reported monoclonal antibodies, notable differences include the lack of reactivity of CU18, CU26, and CU46 with lactating mammary gland and with gastrointestinal malignancies. BCA-225 binds to wheat germ lectin, not to concanavalin A, but monoclonal antibody binding does not appear to involve the carbohydrate component of the molecule. The frequency of the immunocytochemical detection of BCA-225 in breast carcinomas and its restricted distribution in other human tissues suggest considerable clinical potential for this antigen and its corresponding monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3341450      PMCID: PMC1880528     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens.

Authors:  T Feizi
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Pathophysiology of Tamm-Horsfall protein.

Authors:  J R Hoyer; M W Seiler
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Philip Levine Award Lecture. Contributions of quantitative immunochemistry to knowledge of blood group A, B, H, Le, I and i antigens.

Authors:  E A Kabat
Journal:  Am J Clin Pathol       Date:  1982-09       Impact factor: 2.493

6.  Monoclonal antibodies to the human mammary gland. I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues.

Authors:  C S Foster; P A Edwards; E A Dinsdale; A M Neville
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

7.  Molecular recognition and the future of monoclonal antibodies.

Authors:  D Lane; H Koprowski
Journal:  Nature       Date:  1982-03-18       Impact factor: 49.962

8.  Use of monoclonal antibodies to define the diversity of mammary tumor viral gene products in virions and mammary tumors of the genus Mus.

Authors:  D Colcher; P Horan Hand; Y A Teramoto; D Wunderlich; J Schlom
Journal:  Cancer Res       Date:  1981-04       Impact factor: 12.701

9.  Immunohistochemical detection of a cross-reacting virus antigen in mouse mammary tumors and human breast carcinomas.

Authors:  R Mesa-Tejada; I Keydar; M Ramanarayanan; T Ohno; C Fenoglio; S Spiegelman
Journal:  J Histochem Cytochem       Date:  1978-07       Impact factor: 2.479

10.  Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers.

Authors:  J Arklie; J Taylor-Papadimitrious; W Bodmer; M Egan; R Millis
Journal:  Int J Cancer       Date:  1981-07-15       Impact factor: 7.396

View more
  7 in total

1.  Recurrent Breast Cancer at 21 years after Resection Detected by Serum Tumor Markers and Manifested as Dermatomyositis.

Authors: 
Journal:  Breast Cancer       Date:  1994-07-30       Impact factor: 4.239

2.  Characterization of cancer cell lines established from two human metastatic breast cancers.

Authors:  S K Nayak; S Kakati; S R Harvey; C C Malone; A N Cornforth; R O Dillman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-03       Impact factor: 2.416

3.  Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer.

Authors:  H Iwase; S Kobayashi; Y Itoh; H Fukuoka; T Kuzushima; H Iwata; T Yamashita; A Naitoh; K Itoh; A Masaoka
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

4.  Immunohistochemical Analysis of the Expression of Breast Markers in Basal-like Breast Carcinomas Defined as Triple Negative Cancers Expressing Keratin 5.

Authors:  Tamás Zombori; Gábor Cserni
Journal:  Pathol Oncol Res       Date:  2017-05-03       Impact factor: 3.201

5.  Critical evaluation of monoclonal antibody staining in breast carcinoma.

Authors:  D M Parham; G Coghill; A J Robertson
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

6.  Modulation of the antigenic phenotype of human breast carcinoma cells by modifiers of protein kinase C activity and recombinant human interferons.

Authors:  J A Leon; M C Gutierrez; H Jiang; A Estabrook; S Waxman; P B Fisher
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

7.  Immunohistochemical markers in the identification of metastatic breast cancer.

Authors:  P C de Almeida; C B Pestana
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.